Novavax shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Novavax (NVAX) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Novavax
Tip: Access up to 7 years of quarterly data
All positions including Novavax held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Novavax by Ubs Global Asset Management Americas
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $340k | 71k | 4.80 |
2023-09-30 | $726k | 100k | 7.24 |
2023-06-30 | $922k | 133k | 6.93 |
2023-03-31 | $922k | 133k | 6.93 |
2022-12-31 | $1.0M | 99k | 10.28 |
2022-09-30 | $1.8M | 99k | 18.20 |
2022-06-30 | $6.0M | 117k | 51.43 |
2022-03-31 | $16M | 220k | 73.65 |
2021-12-31 | $31M | 219k | 143.07 |
2021-09-30 | $46M | 220k | 207.31 |
2021-06-30 | $63M | 296k | 212.31 |
2021-03-31 | $31M | 172k | 181.31 |
2020-12-31 | $18M | 169k | 108.35 |
2020-09-30 | $18M | 169k | 108.35 |
2020-06-30 | $3.9M | 46k | 83.35 |
2019-09-30 | $101k | 20k | 5.02 |
2019-06-30 | $91k | 16k | 5.86 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas